BPC-157 and TB-500 bodybuilding claims: what the evidence says

What did @pumpsauce.com actually say?

The creator argued that a peptide, almost certainly CJC-1295 without DAC (also called Mod GRF 1-29), has a half-life of "literally almost like 10 minutes" and therefore "shouldn't be taking this by itself." They recommended pairing it with ipamorelin, GHRP-2, or GHRP-6 to make the protocol worthwhile, and acknowledged that by itself its only real job is to increase growth hormone output.

That is a reasonable, fairly informed take for a TikTok bodybuilding account. It is not complete, and it glosses over some important distinctions, but the core argument is not wrong. Let's break down what holds up and what doesn't.

Does the science back this up?

The short half-life point is accurate. The stacking logic has real pharmacological support, but the reasoning is oversimplified in ways that matter.

Mod GRF 1-29, the version of CJC-1295 without the Drug Affinity Complex (DAC), has a plasma half-life of roughly 15 to 30 minutes in research models, not quite "10 minutes," but in the same ballpark compared to the hours-long half-life of CJC-1295 with DAC. The distinction between these two molecules is not mentioned in the video at all, which is a significant omission.

The stacking rationale does have pharmacological grounding. Mod GRF 1-29 is a GHRH analogue that triggers the pituitary to release growth hormone. Ipamorelin and the GHRP compounds (GHRP-2, GHRP-6) work through the ghrelin receptor via a separate pathway. Combining both classes creates a synergistic GH pulse. Alba et al. (2006, Journal of Clinical Endocrinology and Metabolism) demonstrated that GHRH analogues combined with ghrelin-pathway secretagogues produce significantly larger GH pulses than either compound alone.

What did they get wrong (or right)?

The creator got the directional claim right but shaved off the nuance in ways that could genuinely mislead someone shopping for peptides.

First, the half-life number. Saying "almost like 10 minutes" for Mod GRF 1-29 is an underestimate. Published pharmacokinetic data puts the active window closer to 15 to 30 minutes. That is still short enough to make the stacking argument valid, but precision matters when people are using this information to make decisions about injectable compounds.

Second, the video never distinguishes between CJC-1295 with DAC and without DAC. These are different molecules with dramatically different half-lives. CJC-1295 with DAC has a half-life of approximately 6 to 8 days (Ionescu and Frohman, 2006, Journal of Clinical Endocrinology and Metabolism). If someone hears "CJC-1295 has a 10-minute half-life" and then sources CJC-1295 with DAC, they are operating on completely wrong assumptions.

• Mod GRF 1-29 (no DAC): half-life roughly 15-30 minutes. Stacking with a GHRP makes sense.
• CJC-1295 with DAC: half-life roughly 6-8 days. The stacking logic still applies, but timing is different.
• GHRP-2 and GHRP-6 are not identical to ipamorelin. GHRP-6 in particular is associated with significant appetite stimulation via ghrelin pathway activation, which ipamorelin largely avoids.

What should you actually know?

The "stack it or skip it" advice is popular in bodybuilding circles for a reason, but the details matter more than TikTok allows for.

The synergy between GHRH analogues and GHRP-class compounds is the most consistently supported concept in peptide GH secretagogue research. Bowers et al. (1990, Endocrinology) established the synergistic mechanism decades ago, and it has been replicated repeatedly. But "synergistic" does not mean you can ignore the individual pharmacokinetics of whichever specific compound you are actually using.

The GHRP compounds the creator lists are not interchangeable. Ipamorelin has a cleaner selectivity profile, with less cortisol and prolactin elevation than GHRP-2 or GHRP-6 (Raun et al., 1998, European Journal of Endocrinology). GHRP-6 produces notable hunger stimulation. These are not trivial differences for someone managing body composition.

It is also worth stating plainly: none of these peptides are FDA-approved for bodybuilding or general optimization purposes. Research into GHRH analogues and GH secretagogues exists primarily in the context of GH deficiency and clinical wasting syndromes, not healthy adults trying to add muscle. The long-term safety data in healthy populations is limited.

Bottom line

The creator is working from a real pharmacological concept, not making things up. The half-life framing is directionally correct but imprecise, and the failure to distinguish between CJC-1295 with and without DAC is a meaningful gap. If you are evaluating peptide protocols, the source molecule matters as much as the stacking strategy.